Printer Friendly

Company signs research agreement with Pfizer to study adipose tissue.

JUPITER, Fla., May 22, 2014 -- BioRestorative Therapies, Inc. (BRTX) has entered into a two-year collaborative research agreement with Pfizer Inc. to study human brown adipose tissue and cell lines.

BRT and Pfizer will jointly conduct a study titled "Development and Validation of a Human Brown Adipose Cell Model," which will seek to further characterize the identity and metabolic function of these cell lines.

BRT has accumulated a large collection of human brown adipose tissue samples, preadipocyte cell lines and immortalized cell lines for use in potentially developing a cell therapy product. The results of the research may be used by both companies.

Brown fat is a population of adipose (fat) tissue found in the human body and plays a key role in the evolutionarily conserved mechanisms underlying energy homeostasis in mammals.

In June 2011, BRT launched the initial research phase of what it believes will develop into a technology that involves the use of brown fat in a cell-based therapeutic program referred to as the ThermoStem Program. The program will focus on treatments for type 2 diabetes and obesity, as well as for hypertension, other metabolic disorders and cardiac deficiencies, and will involve the study of stem cells, several genes, proteins and/or mechanisms that are related to these diseases and disorders.

Contact: http://www.biorestorative.com

COPYRIGHT 2014 DataTrends Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Strategic Alliances
Publication:Stem Cell Lab World
Date:Jun 2, 2014
Words:217
Previous Article:Clinical trial in age-related macular degeneration advances to final cohort.
Next Article:Companies partner to study novel drug targets in cardiovascular disease.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters